fbpx

Martin Voet retired from a legal career in intellectual property matters following 20 years as Senior Vice President and Chief Intellectual Property Counsel for Allergan, a Fortune 500 Pharma Company, with worldwide responsibility for patenting and licensing pharmaceutical and biological products, patent enforcement and strategic IP planning. Since then he has been Adjunct Professor at USD Law School and consultant for research-based pharmaceutical companies.

He was awarded a BS in Chemistry from UC Berkeley, an MBA from Pepperdine University School of Business and a JD with Honors from The George Washington University School of Law.

He is the author of The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management (6th edition, 2020) and Re-Purposing and Enforcement during Patent Term Extensions for Pharma Products, Landslide Magazine, July/August 2016.